From 2012 to 2022, the Pharmaceuticals in Dosage market in Brazil exhibited fluctuating trends. Values peaked in 2014 at $157.11 per capita, followed by a sharp decline in 2015. After 2018, the market struggled to regain stability, with a significant drop to $117.6 in 2022.
Recent Trends (2022-2024):
- 2022-2023: Expected slight increase. - 2023-2024: Projected marginal improvement.
5-Year CAGR (2018-2023): The average annual change over this period remains negative, indicating persistent market challenges.
Future Trends to Watch: - Emerging healthcare policies that could impact pharmaceutical pricing. - Economic recovery post-pandemic, possibly boosting market demand. - Innovations and approvals in drug formulations which may disrupt current market dynamics.
| # | 59 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 1,580 | 2023 | View data | ||
| 2 | 2 Germany | 1,460 | 2023 | View data | ||
| 3 | 3 Denmark | 1,300 | 2023 | View data | ||
| 4 | 4 Iceland | 1,220 | 2023 | View data | ||
| 5 | 5 Norway | 1,070 | 2023 | View data | ||
| 36 | 36 Honduras | 126.46 | 2023 | View data | ||
| 37 | 37 South Africa | 117.86 | 2023 | View data | ||
| 38 | 38 Brazil | 115.83 | 2023 | |||
| 39 | 39 Malaysia | 114.42 | 2023 | View data | ||
| 40 | 40 Belarus | 112.6 | 2023 | View data | ||
